Overview
LKFT market data
Price History
LKFT price chart
Valuation & Profitability
- P/E (TTM)
- 3.46 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $4.87 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.40 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $22.62 – $27.12 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.7K · P/S 1.74.
Company news
Lakefront Biotherapeutics Receives Transparency Notification As Madison Avenue Partners Crossed Above 5% Of Voting RightsBenzinga · Jun 29, 2026, 8:10 PM
Lakefront Biotherapeutics Repurchases 38,537 Of Its Own Shares Through June 9 - June 12Benzinga · Jun 16, 2026, 8:10 PM
Lakefront Biotherapeutics Says Bank Of America Raised Its Stake To 9.3% Through Voting Rights And Financial InstrumentsBenzinga · May 26, 2026, 8:04 PM